1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Clear-cell Kidney Carcinoma: new trials by email Literature Review of Clear-cell Kidney Carcinoma trials Research Report on Clear-cell Kidney Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma Avelumab, Sunitinib - Clear-cell Renal Cell Carcinoma, RCC | Phase 2 | Withdrawn | Guru Sonpavde | 2017-05-23 | 2022-02-15 |
Carcinoma, Renal Cell (1) · Kidney Neoplasms (1)
Adenocarcinoma (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Guru Sonpavde (1)
United States (1)